Affimed (Nasdaq: AFMD) is a clinical stage biopharmaceutical company which engineers targeted immunotherapies, seeking to improve patient outcomes through the power of innate immunity. Affimed’s fit-for-purpose ROCK® platform allows innate immune engagers to be designed for specific patient populations. We are developing single and combination therapies to treat cancers.
To strengthen our highly motivated Operations Team in Heidelberg, Germany, we are looking for a full-time
(Reference No. OP2104)
You will be involved in front-line and challenging research and development projects on novel technologies in the fields of cell therapy and therapeutic antibodies that enables the development and characterization of our product candidates.
The successful candidate will have the unique opportunity to work in a dynamic, highly motivated, multidisciplinary, and collegial team.
For any queries, please contact Susanne Hering (Tel: 06221 6743 675, e-mail: firstname.lastname@example.org).